Published in

American Society of Hematology, Blood Advances, 15(3), p. 2312-2316, 2019

DOI: 10.1182/bloodadvances.2019000034

Links

Tools

Export citation

Search in Google Scholar

Ponatinib treatment promotes arterial thrombosis and hyperactive platelets

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Key Points Ponatinib therapy heightens arterial thrombosis and platelet reactivity. Concurrent pioglitazone treatment reverses heightened thrombosis risk and platelet reactivity induced by ponatinib.